Application to the European Medicines Agency (EMA) covers ANOC-001 as the initial product in the company’s VIDAR-1 Phase I/II multi-asset ...
Laboratory experiments with cancer cells have revealed two ways in which tumors evade drugs designed to starve and kill them.
News Medical on MSN13h
Study reveals how cancer cells evade chemotherapy in low-glucose environmentsLaboratory experiments with cancer cells reveal two ways in which tumors evade drugs designed to starve and kill them, a new study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback